{"id":"W2898479222","doi":"10.1093/annonc/mdy272.283","title":"Ribociclib (RIB) + tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-7 patient-reported outcomes (PROs)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Letrozole; Internal medicine; Clinical endpoint; Anastrozole; Hazard ratio; Aromatase inhibitor; Tamoxifen; Breast cancer; Quality of life (healthcare); Oncology; Goserelin; Progression-free survival; Placebo; Cancer; Randomized controlled trial; Gynecology; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009580262,0.0004973694,0.000731942,0.0002551049,0.0001316998,0.0003386702,0.000398965,0.0004359818,0.003235688],"category_scores_gemma":[0.0006147127,0.0002135538,0.0007281979,0.000337892,0.0004334195,0.0002943341,0.0002677441,0.00104255,0.0004265997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004034014,"about_ca_system_score_gemma":0.000597738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005678291,"about_ca_topic_score_gemma":0.004126374,"domain_scores_codex":[0.9997434,0.0001498304,0.00001650827,0.00002692677,0.0000226316,0.00004064863],"domain_scores_gemma":[0.9997357,0.00005993572,0.00009885792,0.00001683286,0.00001077997,0.00007808836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8525564,0.01033191,0.008773162,0.00157317,0.002053761,0.00007916184,0.00010055,0.001463137,0.01522995,0.0002117455,0.001981099,0.1056459],"study_design_scores_gemma":[0.5195729,0.4304386,0.03835694,0.0001372679,0.002574083,0.0002264652,0.00006824401,0.001056256,0.003487734,0.0002074331,0.003848206,0.00002596055],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913663,0.005033562,0.0001986515,0.0003203436,0.0000646734,0.0006100879,0.0007091829,0.00003695714,0.00166018],"genre_scores_gemma":[0.9935483,0.002449279,0.0004771317,0.0003992693,0.00009894198,0.0007736518,0.0008259241,0.000006718334,0.001420794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003235688,"threshold_uncertainty_score":0.0108245,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02436245564952375,"score_gpt":0.3395648336872037,"score_spread":0.3152023780376799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}